GAIL SPIRIDIGLIOZZI, M.D.
Medical Practice at Erwin Rd, Durham, NC

License number
North Carolina 101639
Category
Medical Practice
Type
Pediatrics
Address
Address
2100 Erwin Rd, Durham, NC 27710
Phone
(919) 620-4467

Personal information

See more information about GAIL SPIRIDIGLIOZZI at radaris.com
Name
Address
Phone
Gail Spiridigliozzi
4714 Highgate Dr, Durham, NC 27713
(919) 544-5665
Gail Spiridigliozzi, age 66
4909 Stockton Way, Durham, NC 27707
(919) 544-5665
Gail Spiridigliozzi
Durham, NC
(919) 544-5665
Gail A Spiridigliozzi, age 65
1 Dardanelle Ln, Durham, NC 27713
(919) 544-5665
Gail A Spiridigliozzi
2433 Scots Pine Xing, Durham, NC 27713
(919) 806-8317

Professional information

See more information about GAIL SPIRIDIGLIOZZI at trustoria.com
Gail Spiridigliozzi Photo 1
Dr. Gail Spiridigliozzi, Durham NC - MD (Doctor of Medicine)

Dr. Gail Spiridigliozzi, Durham NC - MD (Doctor of Medicine)

Specialties:
Pediatrics
Address:
Durham Child Dev/Beh Hlth Ctr
402 Trent Dr, Durham 27705
(919) 668-5559 (Phone)
Languages:
English


Gail Spiridigliozzi Photo 2
Cholinergic Therapy For Individuals With Learning Disabilities

Cholinergic Therapy For Individuals With Learning Disabilities

US Patent:
2006012, Jun 15, 2006
Filed:
Jul 22, 2003
Appl. No.:
10/522013
Inventors:
James Heller - Chapel Hill NC, US
Priva Kishnani - Durham NC, US
Gail Spiridigliozzi - Durham NC, US
Gordon Worley - Chapel Hill NC, US
International Classification:
G10L 11/00
US Classification:
704200000
Abstract:
Cholinergic agents are used to improve specific learning deficits and language function in individuals of normal intelligence. Psychosocial deficits including a pragmatics impairment, reading deficits, a problem solving impairment, an information processing impairment, an adaptive function impairment, social skills impairment, attention impairment, a mood impairment and employment skills impairment, can also be treated in this manner. The cholinergic treatments can be combined with more traditional educational, psychological, and behavioral therapies for enhanced therapeutic benefit.